Straumann

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

The history of the Straumann Group has three distinct eras and spans more than half a century. It began in the village of Waldenburg, Switzerland in 1954 with the foundation of a research institute bearing the name of its founder, Dr Ing. Reinhard Straumann.

Between 1954 and 1970, the company specialized in alloys used in timing instruments and in materials testing. Among Straumann's renowned inventions in this period were special alloys that are still used in watch springs today. A breakthrough in the use of non-corroding alloys for treating bone fractures prompted Dr Fritz Straumann to enter the fields of orthopedics and dental implantology, which began the second phase of the company's history.1954

In the small town of Waldenburg, at the foot of the Swiss Jura, Reinhard Straumann founds the "Dr Ing. R. Straumann Research Institute AG".

The Swiss Association for the Study of Internal Fixation is looking for a company that is capable of providing materials for internal fixation implants – Dr H.C. Fritz Straumann, son of the company's founder, gets in touch.

Between 1970 and 1990, Straumann became a leading manufacturer of osteosynthesis implants. A management buy-out of the osteosynthesis division in 1990 led to the creation of Stratec as a separate company. Thomas Straumann, grandson of the founder, headed the remaining part of the firm, which employed just 25 people focused exclusively on dental implants. 1990 thus marked the beginning of the Straumann Group as it is known today.

1980 Straumann established a partnership with the International Team for Implantology. The 1980s also marked the company's geographic expansion, with subsidiaries in Germany and the US .

The first dental implants are developed at the Institut Straumann and undergo successful clinical testing at the University of Berne.

Under the aegis of Dr Fritz Straumann, Waldenburg, and Prof Schroeder, University of Berne, the International Team for Implantology, the ITI, is founded.

After a management buy-out of the internal fixation division, Thomas Straumann focuses the activities of the Institut Straumann AG on the area of implant dentistry.

In 1998, Straumann Holding AG became a publicly traded company on the Swiss exchange. Through the acquisition of Kuros Therapeutics and Biora , Straumann entered the promising field of oral tissue regeneration.

With the opening of the production site in Villeret, located in the Bernese Jura, and the Technology Center in Waldenburg, new dimensions open up for the international Straumann group.

Straumann acquires the Swedish company Biora, a pioneer in the area of biologically based regeneration of dental tissue.

Investment in Dental Wings, a developer and provider of CADCAM software and scanning technology, based in Canada.

The company also invests in the French implant maker Anthogyr to address the non-premium segment in China.

Straumann invests in Botiss Biomedical and fully acquires Createch. The Group also gains control of T-Plus in Taiwan.Additionally, the Straumann Group entered the orthodontics field and strengthened its digital capabilities through acquisitions and alliances: full acquisition of Dental Wings; acquisition of ClearCorrect ; investment in Geniova ; investment in Rapid Shape ; increased investment in Rodo Medical; acquisition of Loop Digital Solutions; partnership with 3Shape .2019

As a leading dental provider, Straumann is renowned for innovation and quality backed by scientific evidence. To drive our mission further, Straumann and its partners have united to form the Straumann Group. By fostering international brands we raise quality and promote global excellence in dentistry.